The GI Cancers Symposium revealed new therapies for specific cancer subsets and progress in chimeric antigen receptor T-cell ...

Progression-free survival was significantly greater in the nivolumab plus ipilimumab group compared to nivolumab alone. 2. Treatment-related adverse events were slightly higher in nivolumab plus ...

Real world data show that immunotherapy leads to better overall survival outcomes than chemotherapy in patients with ...

This is part of a multibillion-rand plan to fill connectivity gaps in the country and increase internet access.

We recently published a list of the 10 Worst Performing Defense Stocks So Far in 2025. In this article, we will take a look ...